Given the predictive values of CBCs, BRAF V600E, and MAP2K1 for LCH, we established a new risk model incorporated NLR, PLR, SII, SIRI, BRAF V600E, and MAP2K1, and evaluated its prognostic value. The gene discussed is MAP2K1; the disease is Langerhans cell histiocytosis.